News
OMIC Blog | Subscribe (RSS) |
- How to Prevent Harm from Improper Use of Single-dose/ Single Use Vials
Every year, ophthalmologists give hundreds of thousands of intravitreal and intraocular injections. The Center for Disease Control (CDC) has been very active in promoting safe injection practices. This CDC Position Paper provides the CDC’s “position” and “general messages” that all ophthalmologists should be aware of and implement in their practice. The following is from the CDC website: http://www.cdc.gov/injectionsafety/ […]
- OMIC Encourages Prompt Reporting of Endophthalmitis in Patients given Brilliant Blue G (BBG)
An alert was released this week by the American Academy of Ophthalmology (AAO) and the Food and Drug Administration (FDA) regarding the use of Brilliant Blue G for eye surgery. (See below) OMIC encourages policyholders who report cases to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program to also call OMIC’s Risk Management Hotline to report […]
- LIVE BLOG: 2012 ASCRS/ASOA Meeting in Chicago
UPDATE: A BIG thank you to the 200 attendees at OMIC’s risk management seminar Professional Liability Risks Associated with Premium IOL Implants yesterday! OMIC insureds earned an average of more than $1,100 in discounts for attending. If you missed the event, there are still plenty of ways to earn your discount. See below for links […]
- HIPAA-proofing Your Smart Phone or Mobile Device
In recent months OMIC has noted a surge in regulatory and HIPAA Privacy claims, especially involving malicious acts by disgruntled employees and unhappy patients. In one case, a physician’s smart phone was compromised and more than 30 unauthorized breaches were recorded in one four hour period, requiring the practice to notify hundreds of patients of […]
